Despite this underlying heterogeneity in underlying biology and treatment strategies, prostate-specific antigen (PSA) has been consistently found to be an indicator of underlying cancer activity and confers important prognostic information [13,14,15,16]. The gene discussed is KLK3; the disease is cancer.